SLC39A9 and hepatocellular carcinoma: These findings indicate that ZIP9 is transcriptionally downregulated not only in HCC patient-derived TAMs but also in human liver cancer tissues, which suggests that ZIP9 may be involved in hepatocarcinogenesis by participating in TAMs differentiation.